Neonatal compressive goiter as the initial presentation of thyroid hormone resistance with dual THRB and TSHR mutations
JCEM Case Reports · 16.10.2026 · 4 (12)
DOI: 10.1210/jcemcr/luag316 ↗Kurz gefasst
Fallbericht in der Zeitschrift JCEM Case Reports, online erschienen am 06.11.2026. Verfasst von Séverine Dubois und 5 weiteren Autor:innen. Beteiligte Einrichtung: APHP North, Paris City University, Pediatric Endocrinology and Diabetes, Rare Disease Center for Growth and Developmental Endocrine Diseases, Robert-…. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Resistance to thyroid hormones (RTH) is a rare disorder mostly caused by mutations in the thyroid hormone receptor β gene (THRB). It typically presents in late childhood or adulthood with elevated free thyroid hormone levels, inappropriately normal or high thyroid-stimulating hormone (TSH), and goiter. We report a case of RTH associated with a compressive neonatal goiter. A preterm newborn presented with respiratory distress due to a large goiter (9.7 mL; normal, <1.53 mL) requiring mechanical ventilation, as well as supraventricular tachycardia. His thyroid hormone profile was consistent with RTH: TSH, 73.8 mIU/L (normal range [NR], 1.5-15.6 mIU/L); free T4, 77.1 pmol/L (59.9 pg/mL; NR, 11.6-36 pmol/L [9.0-28.0 pg/mL]), and free T3, >30 pmol/L (>19.5 pg/mL; NR, 3.5-7.8 pmol/L [2.3-5.1 pg/mL]). Genetic testing and functional analyses identified a de novo heterozygous THRB nonsense mutation and an inherited heterozygous missense activating mutation in the TSHR gene. Treatment with tiratricol reduced TSH levels and goiter size, allowing extubation after 17 days. At 4 years, the patient remains stable on tiratricol. We conclude that the activating TSH receptor mutation is responsible for the neonatal compressive goiter in the context of a loss of function in THRB.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- APHP North, Paris City University, Pediatric Endocrinology and Diabetes, Rare Disease Center for Growth and Developmental Endocrine Diseases, Robert-Debré University Hospital, Paris 75019, France.
- Inserm U1141 NeuroDiderot, Paris City University, Paris F-75006, France.
- Laboratory of Biochemistry and Molecular Biology, IFB-CHU Purpan, Toulouse 31000, France.
- Inserm/UPS UMR 1297, I2MC, Institut des Maladies Métaboliques et Cardiovasculaires, , Toulouse 31432 Cedex 4, France.
- APHP North, Paris City University, Department of Neonatal Intensive Care Unit, Robert-Debré University Hospital, Paris 75019, France.
- APHP North, Paris City University, Laboratory of Biochemistry and Hormonology, Robert-Debré University Hospital, Paris 75019, France.
ORCID-Profile: Frédérique Savagner, Jean-Claude Carel
Zitieren
APA
Dubois, S., Savagner, F., Heneau, A., Azar-Kolakez, A., Al-Amir, I., & Carel, J. C. (2026). Neonatal compressive goiter as the initial presentation of thyroid hormone resistance with dual THRB and TSHR mutations. JCEM Case Reports, 4(12). https://doi.org/10.1210/jcemcr/luag316
Vancouver
Dubois S, Savagner F, Heneau A, Azar-Kolakez A, Al-Amir I, Carel JC. Neonatal compressive goiter as the initial presentation of thyroid hormone resistance with dual THRB and TSHR mutations. JCEM Case Reports. 2026;4(12). doi:10.1210/jcemcr/luag316
BibTeX
@article{Dubois2026,
author = {Dubois, Séverine and Savagner, Frédérique and Heneau, Alice and Azar-Kolakez, Ahlam and Al-Amir, Issam and Carel, Jean-Claude},
title = {Neonatal compressive goiter as the initial presentation of thyroid hormone resistance with dual THRB and TSHR mutations},
journal = {JCEM Case Reports},
year = {2026},
volume = {4},
number = {12},
doi = {10.1210/jcemcr/luag316}
}
EUVIMED